AU4228997A - Method for treating homozygous familial hypercholesterolemia - Google Patents

Method for treating homozygous familial hypercholesterolemia

Info

Publication number
AU4228997A
AU4228997A AU42289/97A AU4228997A AU4228997A AU 4228997 A AU4228997 A AU 4228997A AU 42289/97 A AU42289/97 A AU 42289/97A AU 4228997 A AU4228997 A AU 4228997A AU 4228997 A AU4228997 A AU 4228997A
Authority
AU
Australia
Prior art keywords
familial hypercholesterolemia
homozygous familial
treating
treating homozygous
hypercholesterolemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42289/97A
Inventor
Yale B Mitchel
Jonathan A. Tobert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9617898.3A external-priority patent/GB9617898D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU4228997A publication Critical patent/AU4228997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU42289/97A 1996-07-09 1997-07-03 Method for treating homozygous familial hypercholesterolemia Abandoned AU4228997A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US2142096P 1996-07-09 1996-07-09
US60021420 1996-07-09
GBGB9617898.3A GB9617898D0 (en) 1996-08-28 1996-08-28 Method for treating homozygous familial hypercholesterolemia
GB9617898 1996-08-28
US2935196P 1996-10-31 1996-10-31
US60029351 1996-10-31
PCT/US1997/011792 WO1998001100A2 (en) 1996-07-09 1997-07-03 Method for treating homozygous familial hypercholesterolemia

Publications (1)

Publication Number Publication Date
AU4228997A true AU4228997A (en) 1998-02-02

Family

ID=27268450

Family Applications (3)

Application Number Title Priority Date Filing Date
AU42289/97A Abandoned AU4228997A (en) 1996-07-09 1997-07-03 Method for treating homozygous familial hypercholesterolemia
AU43261/97A Abandoned AU4326197A (en) 1996-07-09 1997-07-03 Pharmaceutical compositions
AU36672/97A Abandoned AU3667297A (en) 1996-07-09 1997-07-03 Therapy for combined hyperlipidemia

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU43261/97A Abandoned AU4326197A (en) 1996-07-09 1997-07-03 Pharmaceutical compositions
AU36672/97A Abandoned AU3667297A (en) 1996-07-09 1997-07-03 Therapy for combined hyperlipidemia

Country Status (2)

Country Link
AU (3) AU4228997A (en)
WO (3) WO1998001116A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030212996A1 (en) * 1996-02-08 2003-11-13 Wolzien Thomas R. System for interconnection of audio program data transmitted by radio to remote vehicle or individual with GPS location
CN1197565C (en) * 1998-09-30 2005-04-20 沃尼尔·朗伯公司 Method for preventing or delaying catheter-based revascularization
DE60206365T2 (en) 2001-03-28 2006-07-06 Schering Corporation, Kenilworth PROCESS FOR THE ENANTIOSELECTIVE SYNTHESIS OF AZETIDINONE INTERMEDIATE PRODUCTS
EP1463804A1 (en) * 2001-12-21 2004-10-06 Rigshospitalet Improved gamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
AR040588A1 (en) 2002-07-26 2005-04-13 Schering Corp PHARMACEUTICAL FORMULATION INCLUDING AN INHIBITOR OF CHOLESTEROL ABSORPTION AND AN INHIBITOR OF A HMGCO TO REDUCTASE
JOP20080381B1 (en) 2007-08-23 2023-03-28 Amgen Inc Antigen Binding Proteins to Proprotein Convertase subtillisin Kexin type 9 (pcsk9)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806564A (en) * 1987-05-26 1989-02-21 Merck & Co., Inc. Antihypercholesterolemic beta-lactones
US4997849A (en) * 1989-06-23 1991-03-05 Merck & Co., Inc. Microbial transformation of simvastatin
US5393893A (en) * 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof

Also Published As

Publication number Publication date
AU3667297A (en) 1998-02-02
AU4326197A (en) 1998-02-02
WO1998001100A3 (en) 1998-02-12
WO1998001116A1 (en) 1998-01-15
WO1998001100A2 (en) 1998-01-15
WO1998001119A2 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
AU1527897A (en) Method for treating the prostate
AU3813397A (en) Apparatus for treating chondromalicia
AU2543097A (en) Method for treating pain
AU2587297A (en) Method for treating pain
AU2326297A (en) Method for treating liquid materials
AU9035498A (en) Method for treating pain
AU1915695A (en) Stormwater treatment system/apparatus
AU3829895A (en) Methods for treating resistant tumors
AU2808997A (en) Method for treating inflammation
AU5362598A (en) Method for improving wastewater treatment
AU2340897A (en) Method for treating pain
EP0722723A3 (en) Phenol derivatives for treating multiple sclerosis
AU4672597A (en) Method for treating urinary reflux
AU4228997A (en) Method for treating homozygous familial hypercholesterolemia
AU3704297A (en) Method
AU3409497A (en) Substances for treating leptin pathway abnormalities
AU6688798A (en) Method for treating lumber
AU9034798A (en) Method for treating pain
AU2991497A (en) Method for odor reduction
AU2542997A (en) Anesthetic method
AU4212597A (en) Method for treating amyotrophic lateral sclerosis
AU3896597A (en) Method for treating substance abuse
AU5369498A (en) Compounds and methods for treating cancer
AU4070897A (en) Method for treating diabetes
AU3740697A (en) Method for treating excessive aggression